AVITA Medical, Inc. SEC filings RCEL

AVITA Medical, Inc. has 376 filings in SEC EDGAR's recent list, going back to Dec 19, 2018. Its latest annual report, Form 10-K, was filed on Feb 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

AVITA Medical, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Nov 2, 2026 Nov 2, 2026
S-8 Employee stock plan registration Aug 25, 2026 —
8-K Current report
Material agreement
Aug 11, 2026 Aug 5, 2026
8-K/A Amended current report
Shareholder vote results
Aug 6, 2026 Jun 3, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Material agreement
Jun 8, 2026 Jun 5, 2026
424B5 Prospectus supplement Jun 8, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 4, 2026 Jun 3, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
May 1, 2026 Apr 30, 2026
DEF 14A Proxy statement Apr 22, 2026 Apr 22, 2026
EFFECT Filing Apr 9, 2026 —
PRE 14A Preliminary proxy statement Apr 8, 2026 Apr 8, 2026
CORRESP Letter to the SEC Apr 7, 2026 —
UPLOAD Letter from the SEC Apr 6, 2026 —
S-3 Shelf registration Mar 31, 2026 —
10-K Annual report Feb 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 12, 2026 Feb 12, 2026
8-K Current report
Material agreement, Agreement ended, Results of operations, New debt, Unregistered share sale
Jan 13, 2026 Jan 13, 2026
8-K Current report
Officer or director change
Jan 5, 2026 Jan 1, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Material agreement, Results of operations
Nov 6, 2025 Nov 5, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 17, 2025 Oct 16, 2025
8-K Current report
Unregistered share sale
Aug 18, 2025 Aug 12, 2025
8-K Current report
Other events
Aug 12, 2025 Aug 12, 2025
S-8 Employee stock plan registration Aug 8, 2025 —
424B5 Prospectus supplement Aug 8, 2025 —
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Material agreement, Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Officer or director change
Aug 6, 2025 Aug 6, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 5, 2025 Jun 4, 2025
8-K Current report
Bylaw or fiscal year change
May 15, 2025 May 15, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
DEF 14A Proxy statement Apr 22, 2025 Apr 22, 2025
PRE 14A Preliminary proxy statement Apr 11, 2025 Apr 11, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Mar 17, 2025 Mar 17, 2025
424B5 Prospectus supplement Feb 14, 2025 —
10-K Annual report Feb 13, 2025 Dec 31, 2024
8-K Current report
Material agreement, Results of operations
Feb 13, 2025 Feb 13, 2025
8-K Current report
Results of operations
Jan 7, 2025 Jan 7, 2025
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations, Other events
Nov 7, 2024 Nov 7, 2024
S-8 Employee stock plan registration Aug 8, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Jul 31, 2024 Jul 31, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 1, 2024 Jun 28, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 6, 2024 Jun 5, 2024
8-K Current report
Other events
May 30, 2024 May 29, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
DEF 14A Proxy statement Apr 23, 2024 Apr 23, 2024
ARS Annual report to shareholders Apr 23, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 11, 2024 Apr 10, 2024
PRE 14A Preliminary proxy statement Apr 4, 2024 Apr 4, 2024
10-K Annual report Feb 22, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 22, 2024 Feb 22, 2024
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Jan 10, 2024 Jan 10, 2024
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Officer or director change
Oct 23, 2023 Oct 20, 2023
8-K Current report
Material agreement, Results of operations, New debt
Oct 18, 2023 Oct 18, 2023
424B5 Prospectus supplement Oct 18, 2023 —
8-K Current report
Other events
Oct 2, 2023 Oct 2, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
S-8 Employee stock plan registration Jun 30, 2023 —
8-K Current report
Regulation FD disclosure
Jun 26, 2023 Jun 26, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 16, 2023 Jun 15, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 7, 2023 Jun 6, 2023
ARS Annual report to shareholders May 30, 2023 Dec 31, 2022
8-K/A Amended current report
Results of operations
May 16, 2023 May 11, 2023
8-K Current report
Results of operations, Officer or director change
May 12, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
EFFECT Filing Apr 25, 2023 —
424B2 Prospectus Apr 25, 2023 —
CORRESP Letter to the SEC Apr 21, 2023 —
8-K Current report
Other events
Apr 21, 2023 Apr 20, 2023
UPLOAD Letter from the SEC Apr 18, 2023 —
S-3 Shelf registration Apr 14, 2023 —
DEF 14A Proxy statement Apr 14, 2023 Jun 6, 2023
PRE 14A Preliminary proxy statement Apr 3, 2023 Jun 6, 2023
8-K Current report
Officer or director change, Other events
Mar 27, 2023 Mar 22, 2023
8-K Current report
Officer or director change
Mar 22, 2023 Mar 16, 2023
8-K Current report
Officer or director change
Mar 21, 2023 Mar 16, 2023
8-K Current report
Other events
Mar 8, 2023 Mar 7, 2023
8-K Current report
Regulation FD disclosure
Mar 2, 2023 Feb 28, 2023
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Other events
Feb 10, 2023 Feb 9, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 20, 2023 Jan 19, 2023
8-K Current report
Other events
Dec 20, 2022 Dec 19, 2022
8-K Current report
Shareholder vote results, Regulation FD disclosure
Dec 14, 2022 Dec 12, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 10, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Other events
Nov 9, 2022 Nov 3, 2022
DEF 14A Proxy statement Oct 19, 2022 Dec 12, 2022
PRE 14A Preliminary proxy statement Oct 7, 2022 Dec 12, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 30, 2022 Sep 26, 2022
8-K Current report
Regulation FD disclosure
Sep 22, 2022 Sep 20, 2022
8-K Current report
Other events
Sep 13, 2022 Sep 12, 2022
8-K Current report
Other events
Sep 2, 2022 Sep 1, 2022
8-K Current report
Regulation FD disclosure
Aug 30, 2022 Aug 29, 2022
8-K Current report
Results of operations, Other events
Aug 12, 2022 Aug 11, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Other events
Jul 22, 2022 Jul 22, 2022
8-K Current report
Results of operations
May 17, 2022 May 12, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Other events
May 10, 2022 May 9, 2022
8-K Current report
Other events
Apr 29, 2022 Apr 28, 2022
8-K Current report
Officer or director change, Other events
Apr 21, 2022 Apr 19, 2022
8-K Current report
Other events
Apr 5, 2022 Apr 4, 2022
8-K Current report
Other events
Mar 24, 2022 Mar 21, 2022
8-K Current report
Other events
Mar 9, 2022 Mar 8, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Mar 4, 2022 Mar 2, 2022
8-K Current report
Results of operations
Mar 1, 2022 Feb 28, 2022
10-KT Transition report Feb 28, 2022 Dec 31, 2021
8-K Current report
Other events
Feb 24, 2022 Feb 23, 2022
8-K Current report
Other events
Feb 18, 2022 Feb 17, 2022
8-K Current report
Other events
Feb 3, 2022 Feb 2, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jan 11, 2022 Jan 10, 2022
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
Dec 23, 2021 Dec 22, 2021
8-K Current report
Regulation FD disclosure
Dec 15, 2021 Dec 14, 2021
DEFA14A Additional proxy material Dec 15, 2021 —
8-K Current report
Other events
Dec 15, 2021 Dec 14, 2021
8-K Current report
Other events
Dec 9, 2021 Dec 8, 2021
8-K Current report
Other events
Dec 6, 2021 Dec 3, 2021
8-K Current report
Results of operations, Bylaw or fiscal year change, Other events
Nov 12, 2021 Nov 8, 2021
DEF 14A Proxy statement Nov 9, 2021 Dec 14, 2021
10-Q Quarterly report Nov 8, 2021 Sep 30, 2021
PRE 14A Preliminary proxy statement Oct 29, 2021 Dec 14, 2021
8-K Current report
Results of operations, Other events
Aug 27, 2021 Aug 26, 2021
10-K Annual report Aug 26, 2021 Jun 30, 2021
8-K Current report
Results of operations, Other events
Aug 17, 2021 Aug 12, 2021
8-K Current report
Other events
Jun 30, 2021 Jun 28, 2021
8-K Current report
Results of operations
Jun 17, 2021 Jun 15, 2021
8-K Current report
Officer or director change
Jun 4, 2021 May 28, 2021
8-K Current report
Results of operations
May 24, 2021 May 13, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
8-K Current report
Other events
Apr 13, 2021 Apr 9, 2021
8-K Current report
Material agreement, Officer or director change
Mar 24, 2021 Mar 22, 2021
UPLOAD Letter from the SEC Mar 19, 2021 —
10-K/A Amended annual report Mar 11, 2021 Jun 30, 2020
8-K Current report
Other events
Mar 4, 2021 Mar 1, 2021
8-K Current report
Material agreement, Other events
Mar 1, 2021 Feb 24, 2021
424B5 Prospectus supplement Feb 26, 2021 —
424B5 Prospectus supplement Feb 24, 2021 —
CORRESP Letter to the SEC Feb 19, 2021 —
10-Q Quarterly report Feb 16, 2021 Dec 31, 2020
UPLOAD Letter from the SEC Feb 10, 2021 —
8-K Current report
Results of operations
Jan 12, 2021 Jan 12, 2021
8-K Current report
Bylaw or fiscal year change
Dec 2, 2020 Dec 2, 2020
8-K Current report
Material agreement, Officer or director change
Dec 2, 2020 Dec 1, 2020
S-8 Employee stock plan registration Nov 24, 2020 —
8-K Current report
Shareholder vote results
Nov 12, 2020 Nov 9, 2020
10-Q Quarterly report Nov 10, 2020 Sep 30, 2020
8-K Current report
Other events
Nov 10, 2020 Nov 9, 2020
8-K Current report
Officer or director change
Nov 6, 2020 Nov 5, 2020
8-K Current report
Other events
Nov 5, 2020 Nov 4, 2020
DEFA14A Additional proxy material Nov 5, 2020 —
8-K Current report
Other events
Nov 2, 2020 Oct 29, 2020
DEFA14A Additional proxy material Nov 2, 2020 —
EFFECT Filing Oct 16, 2020 —
UPLOAD Letter from the SEC Oct 15, 2020 —
CORRESP Letter to the SEC Oct 15, 2020 —
8-K Current report
Other events
Oct 13, 2020 Oct 11, 2020
S-3 Shelf registration Oct 9, 2020 —
DEF 14A Proxy statement Sep 25, 2020 Oct 29, 2020
PRE 14A Preliminary proxy statement Sep 14, 2020 Sep 14, 2020
8-K Current report
Officer or director change
Sep 10, 2020 Sep 6, 2020
8-K Current report
Results of operations
Aug 31, 2020 Aug 27, 2020
8-K Current report
Other events
Aug 28, 2020 Aug 26, 2020
S-8 Employee stock plan registration Aug 27, 2020 —
10-K Annual report Aug 27, 2020 Jun 30, 2020
8-K Current report
Officer or director change
Aug 4, 2020 Aug 3, 2020
15-12B Deregistration Jul 20, 2020 —
8-K Current report
Other events
Jul 13, 2020 Jul 13, 2020
8-K Current report
Results of operations, Other events
Jul 9, 2020 Jul 9, 2020
8-K Current report
Auditor change
Jul 6, 2020 Jun 30, 2020
8-K12B Filing Jun 30, 2020 Jun 30, 2020
6-K Current report (foreign issuer) Jun 22, 2020 Jun 22, 2020
6-K Current report (foreign issuer) Jun 15, 2020 Jun 15, 2020
6-K Current report (foreign issuer) Jun 11, 2020 Jun 11, 2020
6-K Current report (foreign issuer) May 12, 2020 May 12, 2020
6-K Current report (foreign issuer) May 11, 2020 May 11, 2020
6-K Current report (foreign issuer) Apr 29, 2020 Apr 29, 2020
6-K Current report (foreign issuer) Apr 20, 2020 Apr 20, 2020
6-K Current report (foreign issuer) Apr 15, 2020 Apr 6, 2020
6-K Current report (foreign issuer) Feb 19, 2020 Feb 18, 2020
6-K Current report (foreign issuer) Feb 3, 2020 Feb 3, 2020
6-K Current report (foreign issuer) Dec 6, 2019 Dec 5, 2019
6-K Current report (foreign issuer) Nov 27, 2019 Nov 27, 2019
D Filing Nov 27, 2019 —
20-F/A Amended annual report (foreign issuer) Nov 19, 2019 Jun 30, 2019
6-K Current report (foreign issuer) Nov 13, 2019 Nov 13, 2019
6-K Current report (foreign issuer) Nov 1, 2019 Oct 31, 2019
6-K Current report (foreign issuer) Nov 1, 2019 Oct 31, 2019
20-F Annual report (foreign issuer) Oct 31, 2019 Jun 30, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
RCEL (Nasdaq), AVHHL (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Valencia, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1762303
Former names
Avita Therapeutics, Inc. (until Dec 10, 2020); Avita Medical, Ltd. (until Jun 30, 2020)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.